🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial was to evaluate whether zanubrutinib can ef...
Status
Completed
Location
Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital
Start Date
2021-08-11
Trial ID
NCT05068440
Treatments Being Tested
This was a single-arm, multicenter, Phase 2 study to evaluate the efficacy ...
Status
Unknown
Location
Shanghai Changzheng Hospital
Start Date
2023-08-01
Trial ID
NCT05979948
Treatments Being Tested
The primary objective of this study is to evaluate the safety of zanubrutin...
Status
Completed
Location
Rocky Mountain Cancer Centers (Williams) Usor
Start Date
2019-10-15
Trial ID
NCT04116437
Treatments Being Tested
This is a prospective, multicenter, single-arm, open phase II study to expl...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2024-08-31
Trial ID
NCT06554600
Treatments Being Tested
Background. Zanubrutinib and acalabrutinib are both associated with an incr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-22
Trial ID
NCT07283965
Treatments Being Tested
Primary Objective: To compare the complete response rate (CR rate) after in...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-23
Trial ID
NCT07505849
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Zanubru...
Status
Recruiting
Location
Ruijin Hospital
Start Date
2023-11-15
Trial ID
NCT06136351
Treatments Being Tested
This study evaluates a personalized treatment strategy for patients with la...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Start Date
2026-05-14
Trial ID
NCT07602322
Treatments Being Tested
In view of the synergistic effects of rituximab, zanubrutinib, and lenalido...
Status
Unknown
Location
Henan cancer hospital
Start Date
2021-05-26
Trial ID
NCT04938297
Treatments Being Tested
This study is being done to evaluate the safety, tolerability and antitumor...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2020-10-06
Trial ID
NCT04477291
Treatments Being Tested